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Abstract
Edible seaweeds are rich in bioactive compounds such as soluble dietary fibers, proteins, 
peptides, minerals, vitamins, polyunsaturated fatty acids and antioxidants. Previously, 
seaweeds were only used as gelling and thickening agents in the food or pharmaceutical 
industries, recent researches have revealed their potential as complementary medicine. 
The red, brown and green seaweeds have been shown to have therapeutic properties 
for health and disease management, such as anticancer, antiobesity, antidiabetic, antihy-
pertensive, antihyperlipidemic, antioxidant, anticoagulant, anti-inflammatory, immuno-
modulatory, antiestrogenic, thyroid stimulating, neuroprotective, antiviral, antifungal, 
antibacterial and tissue healing properties. In proposed chapter, we discussed various 
active compounds include sulphated polysaccharides, phlorotannins, carotenoids (e.g. 
fucoxanthin), minerals, peptides and sulfolipids, with proven benefits against degenera-
tive metabolic diseases. Moreover, therapeutic modes of action of these bioactive compo-
nents and their reports are summarized in this chapter.
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1. Introduction
Consumer interest has been increased from previous decades towards the health food and 
nutrition is the prime focus in formulating the food products. Algae are the organisms capa-
ble of providing bioactive compounds for producing novel medicinal and pharmaceutical 
substances. Algae are widely studied for human nutritional purpose and correspondingly uti-
lized as functional foods [1]. Natural abundance, diverse origin and universal availability of 
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algae makes it an essential source of biologically functional ingredients [2]. The term marine 
algae are generally referred as marine macroalgae or seaweeds [3]. Seaweeds are living 
resources found notably in littoral habitats or attached to rocks. They grow in shallow coastal 
waters as well as in deep sea areas up to a depth of 180 m. These macroscopic algae relatively 
occur in river mouth and saline waters. Seaweeds constitute the basis of the marine food chain 
and are subdivided in to three divisions, namely, brown algae, red algae and green algae [4].
Seaweeds, sometimes referred as edible marine algae, are regarded as good reservoir of com-
pounds with numerous biological and biomedical activities and are most remarkably abun-
dant in sulfated polysaccharides [5]. These have been studied in recent years to develop novel 
pharmaceuticals and potent bioactive substances [6, 7]. Edible macro algae have become a good 
source of food and alternative medicine in Asian countries [8] and in the western countries 
they are extraction specific and used for many industrial applications in food [9], cosmetics 
and pharmaceuticals [10]. The algal biotechnology industry is growing with an aquacul-
ture division that produces large quantities of seaweeds, such as Laminaria, Gracilaria, and 
Spirulina. Additionally, the utilization phycocolloids derived from algae such as algin, agar, 
and carrageenan has developed into a well-established industry [11]. Cultivation of macroal-
gae now contributes to over 90% of the global seaweed demand, with the remainder being 
naturally harvested. Despite the growing worth of algae as a source of food ingredients, the 
industry has developed with only varying amounts of success and its biotechnological appli-
cation are still under-exploited [12].
1.1. Types of seaweeds
At present, algae are divided in to four domains: Bacteria, Plantae, Chromista and Protozoa. 
All these vary greatly in morphology and sizes, which ranges from unicellular to multicel-
lular microalgae or colony forming marine organisms such as macrophytes and seaweeds. 
Macroalgae are traditionally classified based on their characteristic forms and sizes, however 
the most commonly use feature in algal classification is the presence of specific pigments.
Marine algae due to their richness in bioactive compounds may exhibit antioxidant, anti-
inflammatory, anticoagulant, antimicrobial, antiviral, antitumour and hypocholesterolemic 
activity [13]. Since seventeenth century marine macroalgae have long been used for biomedi-
cal purposes because of their potential phytochemical constituents and highly diverse nature. 
Algae can be classified into two groups based on their size: phytoplankton (microalgae) hav-
ing 5000 different species and seaweed (macroalgae) with 6000 species [14].
Natural pigments determine the inherence of marine algae to one of the three algal divisions 
referred to as brown algae (Phaeophyceae), red algae (Rhodophyceae), and green algae (Chlorophyceae), 
respectively [3]. Brown colour of Phaeophyceae is due to the presence of pigment fucoxanthin. 
Red color of Rhodophyceae is often due to the dominance of phycoerythrin and phycocyanin 
pigments over the other pigments such as chlorophyll, carotene and xanthophylls. Green color of 
Chlorophyceae is due the presence of chlorophyll and related compounds in the same concentra-
tion as in higher plants. Some specific commercially important cultivated seaweeds and seaweed 
products include the brown seaweed L. japonica, from the brown seaweed Undaria pinnatifida, 
and Hizikia from Hizikia fusiforme. Biotechnological advances regarding macro algae cultivation 
include establishment of cell and tissue cultures that can biologically synthesize desired com-
pounds, such as eicosanoids, on a large scale under a controlled environment [12].
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1.2. Nutritional profile
Seaweeds have been recently emerged as a potential source of bioactive compounds with 
unique nutritional value and therapeutic activities, and it has become an important field of 
research in food science and technology [15, 16]. One of the main dietary differences between 
Eastern and Western hemispheres is the higher seafood consumption such as fish and marine 
algae [17]. Seaweeds are characterized as distinguished sources of various bioactive com-
pounds with abundance in many minerals and could be utilized as novel functional foods 
which provide health benefit activities. Seaweed tissues are abundant in mineral elements 
such as iron, potassium, sulfur and iodine [18]. Depending upon seasonal conditions and the 
geographic area, macroalgae differs in the content of biochemical elements such as proteins, 
lipids, carbohydrates, vitamins and minerals [19]. Cell surface polysaccharides are respon-
sible for high level of minerals and trace elements due to the retention of inorganic marine 
substances in marine algae [20]. Marine microalgae are considered as potential source of high 
quality proteins. S. platensis is considered as a prime source of bioactive proteins in marine 
environment. Compositional analysis of microalgae proteins clearly indicates that this high 
quality protein can be effectively used as direct supplements or could be used for formulation 
of other health products such as nutraceuticals [21].
Peptides with therapeutic potentials are referred as bioactive peptides and these peptides have 
potential applications in functional foods and nutraceuticals [22] for health improvement and 
better disease control. Chlorella vulgaris, Spirulina platensis, Navicula incerta and Pavalova lutheri 
are few potential algal species that could be used to extract biologically active peptides with 
significant therapeutic potentials is a widely studied marine microalga for extraction of bioac-
tive peptides [23]. Mineral content of some seaweeds may account for up to 50%. Seaweeds 
species of kelp such as Alaria esculenta and Chondrus crispus are important vegetable sources of 
calcium [24]. The percentage of calcium can be as high as 7% of the dry weight and may be up 
to 34% in Halimeda sp. J.V. Lamouroux having calcified green segments [25]. Laminaria digitata 
is extensively used as a supplement for treatment of hypothyroidism and goiter [26]. The con-
tent weightage of calcium may reach 3% of the dry weight in macroalgae such as Fucus and 
Ascophyllum and up to 33.6% in calcified macroalgae such as Phymatolithon calcareum [27]. 
Therefore, consumption of seaweed could be beneficial to those at risk of calcium deficiency 
like pregnant females, teenagers and the elderly [28].
1.3. Bioactive compounds
Numerous metabolites extracted from marine algae possess biological activities. These bioac-
tive compounds have been widely acknowledged because of their potential health benefits 
[3, 29]. Commercial bioactive compounds of algal origin include natural pigments (NPs), 
polyunsaturated fatty acids (PUFAs), lipids, proteins and polysaccharides [15, 16]. Some of 
these bioactive compounds with their sources are mentioned in Table 1. Natural variability in 
the content of bioactive molecules may be attributed to evolutionary relationships, ecological 
and chemical diversification but these should not be considered as limitations to commercial-
ization [30]. Variation in the concentration of bioactive marine compounds of natural algal 
populations are influenced by environmental changes such as light, nutrients, contaminants, 
salinity, CO
2
 availability, pH, temperature and biotic interactions [31].
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Functional materials of marine organisms occur in a wide variety and are enriched with 
polyunsaturated fatty acids, polysaccharides, pigments, minerals, vitamins, enzymes, pheno-
lics and bioactive peptides [46]. Recently, the importance of algae as a source of structurally 
diverse bioactive compounds has been immensely emerged and research showed various bio-
logical activities of these compounds which are antioxidant, immunomodulation, anticoagu-
lation and antiulcerogenic activities [47].
Seaweeds are the sole source of certain valuable phytochemicals, namely agar and carra-
geenan [48]. The richness of edible marine algae in sulfated polysaccharides (SPs) [49] as 
good sources of nutrients, span their uses from the food and pharmaceutical industries to 
biotechnology [5]. These anionic polysaccharide polymers are not only widespread in marine 
algae but also in mammals and invertebrates. Seaweeds are also the most significant sources 
of non-animal SPs and the chemical structure of these polymers vary according to the type 
of algae [50]. Major polysaccharides found in marine algae include fucoidan and laminarans 
found in brown algae, carrageenan in present red algae and ulvan in green algae [4].
Sulphated polysaccharides present in Rhodophyta are known as galactans which are com-
posed of galactose or modified galactose units [51]. The class of Phaeophyta comprises of 
sulfated l-fucose units which are named as fucans. The polysaccharides found in Chlorophyta 
exhibit polydispersity among heteropolysaccharides together with traces of homopolysac-
charides [50]. Carrageenan may also show anticoagulant activity [52], antiviral activity [53], 
Seaweeds Bioactive compounds References
Undaria pinnatifida Fucoxanthin [32]
Porphyra sp. Phycoerythrobilin [33]
Phaeophyceae Sulfated fucoidans [34]
Rhodophyceae Sulfated galactans [35]
Codium fragile Xyloarabinogalactans [36]
Codium cylindricum Sulfated galactan [37]
Sargassum thunbergii Phlorotannins [38]
Saccharina japonica Fucoidans [39]
Eisenia bicyclis Phloroglucinol [39]
Taonamaria atomaria Stypoldione [40]
Laurencia microcladia Sesquiterpene elatol [41]
Corallina pilulifera Ethanolic extract [41]
Schizymenia dubyi Sulfated glucuronogalactan [42]
Lobophora variegate Fucans [43]
Ecklonia cava Phlorotannin 6,6′-bieckol [44]
Porphyria dentate Catechol, rutin and hesperidin [45]
Table 1. Bioactive compounds from different seaweeds.
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and antitumor activity [54]. Marine red algae primarily contain an agaran type polysaccha-
ride, which was separated from Grateloupia filicina and was investigated for its antiangiogenic 
activity.
Fucoidan is a highly complex sulfated polysaccharide found in marine brown algae is also 
present in microorganisms, plants and animals [44]. Fucoidan have been shown to exhibit 
antiviral and anti-inflammatory affect. Anti-metastatic effects of fucoidan obtained from 
Fucus vesiculosus, have been described. Fucoidan could also be reflected as a potential thera-
peutic agent against the metastasized invasive human lung cancer cells. Phloroglucinol bioac-
tives acquired from marine seaweeds have chemical diversity and are much studied for their 
remarkably beneficial biological actions.
Seaweeds have been majorly studied for their biologically active polyphenolic derivatives 
called phlorotannins [43]. Marine brown algae (Phaeophyta) accumulate a variety of phlo-
roglucinol based polyphenols, as phlorotannins [47]. Among marine brown algae, Ecklonia 
cava, Ecklonia stolonifera, Ecklonia kurome, Eisenia bicyclis, Sargassum thunbergii, Hizikia fusifor-
mis, Undaria pinnatifida and Laminaria japonica have been reported to exhibit health beneficial 
activities because phlorotannins. Due to the various biological activities of phlorotannins, 
marine brown algae are known to be a rich source of healthy food [55]. Undaria pinnatifida con-
tain 5–10% fucoxanthin and it is one of the most well-known edible seaweed in Japan. Health 
benefits of fucoxanthin include anticancer effect and it is reported that neoxanthin and fuco-
xanthin cause a significant reduction in growth of prostate cancer cells. Anti-obesity activity 
and anti-inflammatory activity was also demonstrated [56]. Fucoxanthin is other major bio-
functional pigment of brown seaweeds and has been found in high concentration in various 
edible seaweeds including U. Pinnatifida [57].
2. Remedial activities
2.1. Antioxidant activity
Antioxidants may affect the human health in a positive way as they can protect the human 
body against damage by Reactive oxygen species, which attack and impair macromolecules 
such as DNA, proteins and lipids lead to many health disorders such as diabetes, aging, cancer 
and other neurodegenerative diseases [58]. Recently, marine flora and fauna gain consider-
able interest as natural sources for the development of antioxidants in the food and pharma-
ceutical industry. Marine algae represent one of the richest sources of natural antioxidants 
among marine resources [59]. Antioxidant activity of marine derived bioactive peptides has 
been determined through radical scavenging activities which have been detected by electron 
spin resonance spectroscopy method as well as intra cellular free radical scavenging assays. 
The peptide chain contains hydrophobic amino acids which contribute towards their poten-
tial antioxidant activity [60, 61].
Marine algae have various classes of natural polysaccharides including fucoxanthin, phyco-
erythrobilin, chlorophyll-a and their derivatives show potent antioxidant activity. Cho et al. 
[62] suggested that strong antioxidant activity of the Enteromorpha prolifera was caused by 
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chlorophyll-a derivatives, pheophorbidea, rather than phenolic compounds. The antioxi-
dant activity is due to the specific scavenging of oxygen or radicals [63] formed during per-
oxidation or metal-chelating ability [64]. Yan et al. [32] discovered that fucoxanthin show 
strong radical scavenging activity [65] which isolated fucoxanthin from Undaria pinnatifida 
and prepared two fucoxanthin metabolites, fucoxanthinol and halocyn-thiaxanthin. Hence, 
fucoxanthin serves as substitute for synthetic antioxidants in nutraceuticals and pharmaceu-
ticals. Cytoprotective effect of fucoxanthin has been observed in vitro against ROS forma-
tion induced by H
2
O
2
. Two hydroxyl groups are present in the ring structure of fucoxanthin, 
which are responsible for the inhibition of ROS formation. Several studies supported the fact 
that number of hydroxyl groups on the ring structure of fucoxanthin causes the effects of ROS 
suppression [66]. Recently, Yabuta et al. [33] demonstrated antioxidant activity of phycoeryth-
robilin derived from Porphyra sp.
NPs are useful effective bioactive substances in search for effective, non-toxic substances with 
potential antioxidant activity. NPs are distributed in large quantities in marine algae and 
could be used as a rich source of natural antioxidants with potential application in the food 
industry as well as cosmetic and pharmaceutical areas [3].
2.2. Anti-coagulant activity
Whenever an abnormal vascular condition occurs, blood coagulation begins to stop the flow 
of blood though the injured vessel wall and exposure to non-endothelial surfaces at sites of 
vascular injury occur. Blood coagulation is processed by coagulation factors. The blood coag-
ulation can be prolonged or stopped when endogenous or exogenous anticoagulants interfere 
with these coagulation factors [67]. The anticoagulants derived from marine bioactive pep-
tides have been extensively reported, but they have also been isolated from marine organisms 
such as marine echiuroid worm [68]. The anticoagulant activity of the bioactive peptides has 
been determined by prolongation of prothrombin time, thrombin time and activated par-
tial thromboplastin time assays and the activity was compared with the standard commer-
cial anticoagulant heparin. The normal clotting time of anticoagulant peptide isolated from 
marine echiuroid worm have been significantly prolonged [69].
Sulphated polysaccharides derived from marine brown algae are alternate sources for manu-
facturing of novel anticoagulants [37]. Anticoagulant activity is the most extensively studied 
property of sulphated polysaccharides and have been reviewed previously [70]. Two types of 
SPs have been recognized with high anticoagulant activity. Marine red algae produce sulfated 
galactans also known as carrageenan, [35] and marine brown algae produce sulfated fucoid-
ans [34]. There are very few reports of anticoagulant SPs reported from marine green algae. 
Jurd et al. [36] found that the anticoagulant active SPs from Codium fragile contain xyloarabi-
nogalactans. Codium cylindricum also contain a sulfated galactan with anticoagulant activity. 
Additionally, Maeda et al. [71] have revealed that the anticoagulant SPs from Monostroma niti-
dum yield a six fold higher activity as compared to heparin. Marine brown algae extracts dem-
onstrate higher anticoagulant activity than red and green algae extracts [34]. The presence of 
sulfate functional groups in SPs can increase both the specific as well as nonspecific binding 
to a wide-range of biologically active proteins. Anticoagulant activity of sulfated galactans 
depends on the sulfate content, the sulfation position of the structure, and nature of the sugar 
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residue in SPs [72]. High molecular weight carrageenans having high sulfate content show 
higher anticoagulant activity in comparison to low molecular weight carrageenans having 
low sulfate content of SPs [73].
Low molecular weight and unfractionated heparins are the only sulfated polysaccharides 
currently used as anticoagulant drugs. Seaweed derived SPs possess anticoagulant activity 
similar to or higher than the heparin [50]. In the pharmaceutical industry, SPs derived from 
seaweeds are the promising bioactive agents to be used as anticoagulant agents. Phlorotannins 
derived from Sargassum thunbergii are potential anticoagulants in vitro and in vivo. These 
phlorotannins from S. thunbergii had a significant effect on the prolongation of prothrombin 
time, thrombin time and activated partial thromboplastin time. In addition, phloroglucinol 
can be established as a novel anticoagulant in pharmaceutical industry [38].
2.3. Anti-cancer activity
Marine algae produce a range of diverse anti-cancer phytochemicals. Based on epidemiologi-
cal data, the protective effect of edible seaweeds has been established against mammary, skin 
and intestinal carcinogenesis [74]. The bioactive substances can kill cancerous cells by induc-
ing apoptosis or they may affect cell signaling by the activation of cell signaling enzymes 
of protein kinase-c family of brown algae seaweeds [75]. Laminaria, Gelidiumamansii and 
Porphyratenera exhibit dose-dependent inhibition of growth in mutated human gastric and 
colon cells [76] and also cancer cells of mammary glands. Brown seaweeds such as Laminaria 
are edible as a functional food, and it is well known for reducing the incidence of breast cancer 
in Japan to about one sixth as that of the rate reported for American women. Laminaria japonica 
and Sargassum muticum species are widely used as components of conventional herbal medi-
cines for the treatment of cancer in china [77].
Most remarkable compounds found naturally in the brown seaweeds are the fucoidans, glucans 
and some other secondary [75] metabolites. Most of these compounds are listed in (Table 2). 
These compounds are capable of producing anticancer activity. Fucoidans from Saccharina japon-
ica and Undaria pinnatifida dose-dependently inhibit proliferation and colony formation in both 
breast cancer and melanoma cell. This proves that the use of sulfated polysaccharides from both 
above mentioned brown seaweeds are potential ingredients for cancer treatment. Low molecu-
lar weight fucoidan isolated from Ascophyllumnodosum selectively inhibits the invasion of breast 
cancer cells by a mechanism of blocking the accession of these cancerous cells in the extracellular 
matrix and it also inhibits the invasive colon adenocarcinoma cells [78].
Phloroglucinol and its essential polymers which are eckol, dieckol, phlorofucofuroeckol A, 
and 8,8′-bieckol isolated from the brown alga Eisenia bicyclis show significant anticancer activ-
ity [39]. The extract of the brown alga Taonamaria atomaria contains a compound stypoldi-
one, an in-vitro inhibitor of microtubule polymerization, exhibits anticancer activity [40]. Red 
algae contain abundant concentration of secondary metabolites and their halogenated deriva-
tives. Laurencia microcladia produces a sesquiterpene elatol exhibit antitumour activity. Elatol 
exhibits cytotoxicity by inducing cell cycle arrest leading cells to apoptosis. Corallina pilulifera 
is a calcareous red alga whose ethanolic extract show anti-proliferative activity on human cer-
vical adenocarcinoma cells. Acanthospora spicifer, another red seaweed, exhibits tumouricidal 
activity against Ehrlich’s ascites carcinoma cells. This is due to decrease in tumour volume 
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Health claims Bioactive compounds References
Antioxidant activity • Fucoxanthin
• Phycoerythrobilin
• Chlorophyll-a and derivatives
[76]
Anti-coagulant activity • Sulphated polysaccharides
 ○ Galactans/Carrageenan
 ○ Fucoidans
 ○ Heparins
 ○ Phlorotannins
 ○ Phloroglucinol
[37]
Anti-cancer activity • Fucoidans
• Glucans
• Phloroglucinol
• Stypoldione
• Sesquiterpene elatol
• Carotene
• Lutien
[39]
Anti-viral/Anti-HIV activity • Sulfated Glucuronogalactan
• Sulphated galactans
• Sulphated fucans
• Carrageenan
[54]
Cardiovascular protection • Carotenoids
• Sterols
• Cardiac glycosides
• Eicosapentaenoic acid
• Docosa-hexaenoic acid
[81]
Anti-inflammatory activity • Marine terpenes
• Bioactive peptides
• Sulfated Polysaccharides
• Fucoidan
• Ascophyllan
• Algal polyphenols
• Phlorotannins
• Terpenes and steroids
• Alkaloids
• Commercially produced microalgal PUFAs
[82]
Table 2. Bioactive compounds from seaweeds with their health promoting functions.
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and viable cell counts and increase in the mean survival time [41]. Porphyratenera, a red alga, 
has been extensively reported for its high anti-carcinogenic effect [79]. Chlorophyll-related 
compounds, carotene and lutien isolated from algae exhibit strong anti-mutagenic activity 
in vitro as well as in vivo [80].
Various anticancer pathways are involved to accomplish the process of tumour cell death. 
Major pathways are anti-oxidation and immune stimulation, and apoptosis of cancerous 
cells. Tumors are in a ‘pro-oxidant’ state generating more free radicals. These free radi-
cals usually accompanied by lack of DNA repair mechanisms. Reactive oxygen species are 
main sources of oxidative stress in cells, damaging DNA, proteins and lipids. Anti-oxidants 
cause inhibition of the growth of cancer cells through varied mechanisms. The most com-
mon is activation of apoptosis by antioxidant species and inhibition the process of tumour 
progression [64].
Apoptosis is a process of programmed cell death triggered by various extrinsic or intrinsic 
stimuli in unfavourable situations. The protein p53 and caspase-cascade signaling system are 
prime factors for promoting apoptosis [83]. Caspases belong to the interleukin 1β converting 
enzyme family of proteases. The process of apoptosis has three stages, namely activation, 
execution and cell deletion. All these stages are interlinked by caspases [84]. Tumour suppres-
sor protein p53 triggers the apoptosis and induces cell growth arrest. The prevention of can-
cer is highly dependent on p53 for controlling the proliferation of cells with damaged DNA 
or with a potential for neoplastic transformation. Algae is a source of many phytochemicals 
which cause apoptosis. Spirulina and Aphanizomenon fos-aquae are two most common edible 
cyanobacteria [85]. Both contain phycocyanin, which is capable of showing apoptosis in the 
chronic myeloid leukaemia cells. Enzymatic extraction of alga, Ecklonia cava together with its 
polysaccharides and polyphenolics, displays tremendous anti-proliferative activity against 
cancer cell line [75].
The apoptosis is executed immunostimulation with two pathways, the NK cell and Fas recep-
tor mediated pathways. The Fas receptor molecule plays an important role in the immune 
system, which allows the removal of auto-antibodies and the elimination of virally infected 
tumourigenic cells. Immune defence mechanisms do kill any abnormal cells including can-
cer. Polysaccharides are associated with biological activities of several microalgal species. 
Polysaccharide complexes from Chlorella pyrenoidosa contain glucose and any combination 
of mannose, galactose, arabinose, and rhamnose. The complexes N-acetylglucosamide and N 
-acetylgalactosamine have immune stimulating properties and can inhibit the proliferation 
of pathogenic microbes such as Listeria monocytogene sand Candida albicans [75] Enteromorpha 
compressa, produces a range of bioactive compounds which are proved to be useful in the 
treatment of cancer and inflammation [86]. Malyngamides isolated from Lyngbya majuscule 
have immunosuppressant properties and is also cytotoxic [87].
2.4. Anti-viral/Anti- HIV activity
Acquired immunodeficiency syndrome AIDS is a disease caused by human immunode-
ficiency virus (HIV-1) [88]. Marine algae derived SPs can inhibit replication of enveloped 
viruses such as herpes virus, togavirus, arenavirus, rhabdovirus, and orthopoxvirus families. 
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These sulaphated polysaccharides have great potential for the development of novel anti-
HIV therapeutics. Marine algae possess significant quantities of complex structural SPs that 
inhibit the HIV. The chemical structure, constituent sugars, stereochemistry, degree of sulfa-
tion, molecular weight and conformation are affected the antiviral activity of algal SPs [89].
SPs from red algae also exhibit significant HIV-1 inhibitory activity. Anti-HIV activity of 
Schizymenia dubyi is due to sulfated glucuronogalactan. This polysaccharide causes inhibition 
of virus-host cell attachment in vitro. A mechanism which occur mainly during initial step of 
HIV infection [42]. Additionally, antiretroviral activity of sulfated galactans from Grateloupia 
filicina and Grateloupia longifolia was examined with a primary isolate of HIV-1 and human 
peripheral blood mononuclear cells [54]. Sulfated fucans from the brown seaweed F. vesicu-
losus, Lobophora variegata, Dictyota mertensiian and Spatoglossum schroederi were reported to 
inhibit HIV reverse transcriptase [90]. Human papilloma virus is the cause of cervical cancer 
due to infection in female genital tract. Therefore, HPV Infection control has acquired great 
attention from scientific studies [91]. Natural bioactive compounds and their derivatives are 
potential source for the manufacture of functional foods as novel anti-HPV therapeutics with 
fewer side effects, more effective and cost effective. Marine algae contain substantial quanti-
ties of complex structural SPs which are potent inhibitors of wide variety of viruses, such as 
papilloma virus [92].
Carrageenan has been shown to demonstrate anti-HPV activity in vitro [92]. Carrageenan 
inhibits HPV 3-fold higher in magnitude than heparin, a highly effective model for 
HPV. Carrageenan acts mainly by preventing the binding of HPV virions to cells and blocks 
HPV infection through a post attachment heparin sulfate-independent effect. This mecha-
nism is consistent by the fact that carrageenan closely resembles heparin sulfate, which is 
recognized as HPV-cell attachment factor. Moreover, antigen-specific immune responses and 
antitumor effects of carrageenan were remarkable [93]. Carrageenan are the promising can-
didates for production of new therapeutic agents for HPV by being a part of food additives. 
There are numerous advantages of carrageenan over other classes of antiviral agents, such 
as reasonably low production costs, novel modes of action, broad spectrum, low cytotoxicity 
and safety [92].
2.5. Anti-cardiovascular disease activity
Dyslipidemia is a main cardiovascular risk factor for coronary heart disease incidence and 
mortality. Lipid disorders can accelerate the atherosclerosis process and result could be 
chronic heart failure. Nutraceuticals are effectively able to reduce the atherosclerosis process 
and coronary heart disease progression. Carotenoids are produced by seaweeds, plants and 
microorganisms. These fat soluble are the fundamental component of Mediterranean foods, 
are well known to reduce the incidence and frequency of cardiovascular events, perhaps by 
means of their antioxidant action on free radicals or by anti-inflammatory action on lipoxy-
genase enzyme activity [94].
Cell membranes contain sterols as important structural components, and some of them are 
cardiac glycosides used therapeutically in the treatment of cardiac failure and atrial arrhyth-
mias. The positive effect of eicosapentaenoic acid and docosa-hexaenoic acid on human health 
has been reported as far as cardiovascular system. Enrichment of foods with EPA/DHA show 
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cardio protective effects. EPA and DHA may exert their cardio protective functions, namely 
influencing plasmatic triacylglycerol (TAG) and cholesterol levels, and modulation of the 
chronic inflammation in the vascular wall [95].
2.6. Anti-inflammatory activity
Inflammation underlies a mass of enormous malignancies such as asthma, myocardial isch-
emia, allergies, arthritis, atherosclerosis and cancer. Inflammation is a complex biological 
process and occurs in response to harmful stimuli such as presence of pathogens in vascular 
tissues or injury. Inflammation normally acts as a defense mechanism, and its deregulation 
is associated with a multitude of diseases. Chronic and acute inflammation is a physiological 
process mediated by the activation of immune cells such as mononuclear phagocytic cells and 
macrophages [96]. The mechanism of inflammation is controlled by endogenous chemical 
mediators such as vasoactive amines, platelet activating factor, cytokines, bradykinin, fibrin, 
complement component, eicosanoids, nitric oxide and reactive oxygen species. These inflam-
matory mediators play a pivotal role in controlling various steps of inflammation. Marine 
algae produce a diverse array of secondary metabolites which play a pivotal role as inhibitors 
of inflammation [97].
Marine algae produce a combination of metabolites which are implicated in large number of 
diseases because of anti-inflammatory and antioxidant properties, with high commercial uti-
lization. These compounds include fatty acids, marine terpenes, bioactive peptides, polysac-
charides and their structures ranges from aliphatic molecules with a linear chain to complex 
polycyclic entities. Marine sulfated PS exhibit anti-coagulant, anti-inflammatory, anti-viral 
and anti-tumor activities and are important in pharmaceutical industries [82].
These algal compounds usually possess immune-modulatory activities which potentially 
instigate the immune system activities to alleviate undesirable responses such as inflamma-
tion. Sulfated polysaccharides may target numerous pathways in the immune and inflam-
matory systems. They can affect disease pathophysiology and outcome, including tumour 
development and septic shock. Fucoidan possess extensive of biological activities which 
include anti-inflammatory and anti-oxidative effects. Research revealed that the mechanism 
behind anti-inflammatory effect of fucoidan is due to its capability to interact with an adhe-
sion molecule selectin on the seaweed cell membrane [98]. Fucoidan show anti-oxidative effect 
by inhibiting the synthesis and release of reactive oxygen radicals as well as its clearance. Park 
et al. [43] studied the cellular and molecular mechanism underlying the anti-inflammatory 
properties of fucoidan.
According to research, ascophyllan is a discrete sulfated polysaccharide isolated from fucoidan 
with significant biological activity. Lobophora variegate is a brown marine alga, which possess a 
high content of fucans exhibit reduced anti-inflammatory process in vivo. Two sulfated PS from 
Laminaria saccharina, a brown seaweed, utilized for the treatment of inflammation. Sulfated 
polysaccharides of the seaweed L. variegate exhibit antioxidant power and anti-inflammatory 
activity against zymosan induced arthritis [99]. Sulfated PS ‘sacran’ is also of marine algal ori-
gin. A sulfated polysaccharide isolated from Aphanothece sacrum exerts an epicutaneous effect 
on 2,4,6-tncb (picryl chloride) induced allergic dermatitis in vivo by improving functions of 
skin barriers and by decreasing the pro-inflammatory cytokine production [100].
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Algal polyphenols and phlorotannins have numerous biological properties besides their 
strong antioxidant properties. Phlorotannins are the main bioactive compounds found in 
marine algae. Yang et al. [44] proposed the underlying anti-inflammatory mechanism of the 
phlorotannin 6,6′-bieckol, an active component isolated from brown seaweed Ecklonia cava. 
These findings suggest that the anti-inflammatory properties of this compound are related to 
the inhibition of cyclooxygenase-2 and pro-inflammatory cytokines (TNF-αand IL-6).
Porphyria dentate is a red edible seaweed and its use in treatment of inflammatory diseases was 
the long lasting tradition globally. Crude extract of P. dentate contain phenolic compounds such 
as catechol, rutin and hesperidin [45]. Researcher demonstrated that the therapeutic applica-
tions of c-phycocyanin obtained from blue-green algae Spirulina platensis that significantly 
suppress the activation of LPS-induced nitrite and iNOS protein expression, accompanied 
by an attenuation of TNF-α formation. Marine red algae are the source of anti-inflammatory 
cyclic dipeptides and diketopiperazine [101] Terpenes and steroids are the classes of anti-
inflammatory compounds found ubiquitously in marine algae. Heo et al. [102] evaluated the 
potential of fucoxanthin to produce anti-inflammatory effect via inhibition of NO production 
and reduced Prostaglandin-E2 production. Further investigations indicated the suppression 
of iNOS and COX-2 mRNA expressions by fucoxanthin in LPS-stimulate macrophage cells. 
By the addition of fucoxanthin in a dose-dependent manner, the release of cytokines TNF-α, 
IL-1β and IL-6 were also reduced [102].
Alkaloids occur rarely in marine algae, alkaloids isolated from marine algae have been 
shown to possess anti-inflammatory properties [103]. Algal fatty acids are either saturated 
or unsaturated with reported bioactivity. Commercially produced microalgal PUFAs are 
of particular interest because they lead the human body to more anti-inflammatory envi-
ronment. Various benefits accrued from docosahexaenoic acid and palmitoleic acid are 
the reduction in the incidence of certain heart diseases and oleic acid retain antioxidant 
capacity [16].
3. Conclusion
Seaweeds are a valuable source of bioactive compounds and could be introduced for the prep-
aration of novel functional ingredients in food and also a good approach for the treatment or 
prevention of chronic diseases. Recently, much att`ention has been paid by the consumers 
toward natural bioactive compounds as functional ingredients in foods, and hence, it can be 
suggested that, seaweeds are an alternative source for synthetic ingredients that can contrib-
ute to consumer’s well-being, by being a part of new functional foods and pharmaceuticals. 
Furthermore, the wide ranges of biological activities associated with marine algae-derived 
bioactive compounds have potential to expand its health beneficial value in food, and phar-
maceutical industries.
Conflict of interest
Authors declare no potential conflict of interest.
Seaweed Biomaterials18
Author details
Sana Khalid1, Munawar Abbas2, Farhan Saeed2, Huma Bader-Ul-Ain2 and  
Hafiz Ansar Rasul Suleria3,4,5*
*Address all correspondence to: hafiz.suleria@uqconnect.edu.au
1 Department of Pharmaceutical Sciences, Government College University, Faisalabad, 
Pakistan
2 Institute of Home and Food Sciences, Government College University, Faisalabad, 
Pakistan
3 UQ Diamantina Institute, Translational Research Institute, Faculty of Medicine,  
The University of Queensland, Brisbane, Australia
4 Department of Food, Nutrition, Dietetics and Health, Kansas State University,  
Manhattan, KS, USA
5 Centre for Chemistry and Biotechnology, School of Life and Environmental Sciences, 
Deakin University, Waurn Ponds, Australia
References
[1] Holdt SLV, Kraan S. Bioactive compounds in seaweed: Functional food applications and 
legislation. Journal of Applied Phycology. 2011;23(3):543-597
[2] Domanguez H. Algae as a source of biologically active ingredients for the formulation 
of functional foods and nutraceuticals. In: Functional Ingredients from Algae for Foods 
and Nutraceuticals. Cambridge: WoodHead; 2013. pp. 1-19
[3] Pangestuti R, Kim SK. Biological activities and health benefit effects of natural pigments 
derived from marine algae. Journal of Functional Foods. 2011;3(4):255-266
[4] Mayakrishnan V, Kannappan P, et al. Cardioprotective activity of polysaccharides 
derived from marine algae: An overview. Trends in Food Science & Technology. 
2013;30(2):98-104
[5] Renn D. Biotechnology and the red seaweed polysaccharide industry: Status, needs and 
prospects. Trends in Biotechnology. 1997;15(1):9-14
[6] Suleria HAR. Marine Processing Waste-In Search of Bioactive Molecules. Natural 
Products Chemistry and Research. 2016;4:e118
[7] Li B, Lu F, et al. Fucoidan: Structure and bioactivity. Molecules. 2008;13(8):1671-1695
[8] Muhammad SA, Muhammad J, et al. Metabolites of marine algae collected from Karachi-
coasts of Arabian Sea. Natural Product Sciences. 2000;6(2):61-65
[9] Suleria HAR, Gobe G, Masci P, Osborne SA. Marine bioactive compounds and health 
promoting perspectives; innovation pathways for drug discovery. Trends in Food 
Science & Technology. 2016;50:44-55
Therapeutic Potential of Seaweed Bioactive Compounds
http://dx.doi.org/10.5772/intechopen.74060
19
[10] Gamez-Ordaaez E, Jimanez-Escrig A, et al. Dietary fibre and physicochemical proper-
ties of several edible seaweeds from the northwestern Spanish coast. Food Research 
International. 2010;43(9):2289-2294
[11] Tseng C. Algal biotechnology industries and research activities in China. Journal of 
Applied Phycology. 2001;13(4):375-380
[12] Rasmussen RS, Morrissey MT. Marine biotechnology for production of food ingredients. 
Advances in Food and Nutrition Research. 2007;52:237-292
[13] Frestedt JL, Kuskowski MA, et al. A natural seaweed derived mineral supplement 
(Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study. 
Nutrition Journal. 2009;8(1):7
[14] Ravikumar S, Kathiresan K. Influence of tannins, amino acids and sugars on fungi of 
marine halophytes. Mahasagar. 1993;26(1):21-25
[15] Plaza M, Cifuentes A, et al. In the search of new functional food ingredients from algae. 
Trends in Food Science & Technology. 2008;19(1):31-39
[16] Plaza M, Herrero M, et al. Innovative natural functional ingredients from microalgae. 
Journal of Agricultural and Food Chemistry. 2009;57(16):7159-7170
[17] Terry PD, Rohan TE, et al. Intakes of fish and marine fatty acids and the risks of cancers 
of the breast and prostate and of other hormone-related cancers: A review of the epide-
miologic evidence. The American Journal of Clinical Nutrition. 2003;77(3):532-543
[18] Kraan S. Pigments and minor compounds in algae. In: Domanguez H, editor. Functional 
Ingredients from Algae for Foods and Nutraceuticals. Cambridge: WoodHead; 2013. pp. 
205-251
[19] Zubia M, Payri C, et al. Alginate, mannitol, phenolic compounds and biological activi-
ties of two range-extending brown algae, Sargassum mangarevense and Turbinaria ornata 
(Phaeophyta: Fucales), from Tahiti (French Polynesia). Journal of Applied Phycology. 
2008;20(6):1033-1043
[20] Mabeau S, Jl F. Seaweed in food products: Biochemical and nutritional aspects. Trends 
in Food Science & Technology. 1993;4(4):103-107
[21] Brown MR. Nutritional value and use of microalgae in aquaculture. In: Avances 
en Nutrician Acuacola VI. Memorias del VI Simposium Internacional de Nutrician 
Acuacola. 2002;3:281-292
[22] Suleria HAR, Masci P, Gobe G, Osborne S. Current and potential uses of bioactive mol-
ecules from marine processing waste. Journal of the Science of Food and Agriculture. 
2016;96(4):1064-1067
[23] Dewapriya P, Kim SK. Marine microorganisms: An emerging avenue in modern nutra-
ceuticals and functional foods. Food Research International. 2014;56:115-125
[24] Nisizawa K. Seaweeds Kaiso: Bountiful Harvest from the Seas. Japan Seaweed Association. 
Shimane; 2002. pp. 44-50
Seaweed Biomaterials20
[25] Arasaki S, Arasaki T. Vegetables from the Sea. Vol. 96. Tokyo: Japan Publ. Inc.; 1983. 
pp. 251-223
[26] Massig K. Iodine-induced toxic effects due to seaweed consumption. In: Comprehensive 
Handbook of Iodine. Amsterdam: Elsevier; 2009. pp. 897-908
[27] Blunden G, Campbell SA, et al. Chemical and physical characterization of calcified red 
algal deposits known as maarl. Journal of Applied Phycology. 1997;9(1):11-17
[28] Burtin P. Nutritional value of seaweeds. Electronic Journal of Environmental, 
Agricultural and Food Chemistry. 2003;2(4):498-503
[29] Suleria HAR, Osborne S, Masci P, Gobe G. Marine-based nutraceuticals: An innovative 
trend in the food and supplement industries. Marine Drugs. 2015;13:6336-6351
[30] Suleria HR, Butt MS, Anjum FM, Arshad M, Khalid N. Aqueous garlic extract mitigate 
hypercholesterolemia and hyperglycemia; rabbit experimental modelling. Annals of 
Nutrition and Metabolism. 2013;63:271
[31] Stengel DB, Connan SN, et al. Algal chemodiversity and bioactivity: Sources of natu-
ral variability and implications for commercial application. Biotechnology Advances. 
2011;29(5):483-501
[32] Yan X, Chuda Y, et al. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a com-
mon edible seaweed. Bioscience, Biotechnology, and Biochemistry. 1999;63(3):605-607
[33] Yabuta Y, Fujimura H, et al. Antioxidant activity of the phycoerythrobilin compound 
formed from a dried Korean purple laver (Porphyra sp.) during in vitro digestion. Food 
Science and Technology Research. 2010;16(4):347-352
[34] Chevolot L, Foucault A, et al. Further data on the structure of brown seaweed fucans: 
Relationships with anticoagulant activity. Carbohydrate Research. 1999;319(1):154-165
[35] Kolender AA, Pujol CA, et al. The system of sulfated -linked D-mannans from the red 
seaweed Nothogenia fastigiata: Structures, antiherpetic and anticoagulant properties. 
Carbohydrate Research. 1997;304(1):53-60
[36] Jurd KM, Rogers DJ, et al. Anticoagulant properties of sulphated polysaccharides and 
a proteoglycan from Codium fragile ssp. atlanticum. Journal of Applied Phycology. 
1995;7(4):339-345
[37] Matsubara K. Recent advances in marine algal anticoagulants. Current Medicinal 
Chemistry. Cardiovascular and Hematological Agents. 2004;2(1):13-19
[38] Bae JS. Antithrombotic and profibrinolytic activities of phloroglucinol. Food and 
Chemical Toxicology. 2011;49(7):1572-1577
[39] Shibata T, Fujimoto K, et al. Inhibitory activity of brown algal phlorotannins against 
hyaluronidase. International Journal of Food Science and Technology. 2002;37(6):703-709
[40] Mayer AM, Lehmann VK. Marine pharmacology in 1998: Marine compounds with antibac-
terial, anticoagulant, antifungal, antiinflammatory, anthelmintic, antiplatelet,  antiprotozoal, 
Therapeutic Potential of Seaweed Bioactive Compounds
http://dx.doi.org/10.5772/intechopen.74060
21
and antiviral activities; with actions on the cardiovascular, endocrine, immune, and ner-
vous systems; and other miscellaneous mechanisms of action. The Pharmacologist. 
2000;42(2):62-69
[41] Vasanthi H, Rajamanickam G, et al. Tumoricidal effect of the red algae Acanthophora 
spicifera on Ehrlich ascites carcinoma in mice. Seaweed Research and Utilization. 
2004:217-224
[42] Bourgougnon N, Lahaye M, et al. Annual variation in composition and in vitro anti-
HIV-1 activity of the sulfated glucuronogalactan from Schizymenia dubyi (Rhodophyta, 
Gigartinales). Journal of Applied Phycology. 1996;8(2):155-161
[43] Park HY, Han MH, et al. Anti-inflammatory effects of fucoidan through inhibition of 
NF-IB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. 
Food and Chemical Toxicology. 2011;49(8):1745-1752
[44] Yang L, Zhang LM. Chemical structural and chain conformational characterization of 
some bioactive polysaccharides isolated from natural sources. Carbohydrate Polymers. 
2009;76(3):349-361
[45] Kaza-owska K, Hsu T, et al. Anti-inflammatory properties of phenolic compounds and 
crude extract from Porphyra dentata. Journal of Ethnopharmacology. 2010;128(1):123-130
[46] Shahidi F, Alasalvar C. Marine oils and other marine nutraceuticals. In: Handbook of 
Seafood Quality, Safety and Health Applications. Chichestar: Blackwell; 2011. pp. 444-454
[47] Barrow C, Shahidi F. Marine Nutraceuticals and Functional Foods. New York. CRC 
Press; 2007
[48] Ismail A, Hong TS. Antioxidant activity of selected commercial seaweeds. Malaysian 
Journal of Nutrition. 2002;8(2):167-177
[49] Suleria HAR, Masci PP, Zhao KN, Addepalli R, Chen W, Osborne SA, Gobe GC. Anti-
coagulant and anti-thrombotic properties of blacklip abalone (Haliotis rubra): In vitro 
and animal studies. Marine Drugs. 2017;15(8):240
[50] Costa L, Fidelis G, et al. Biological activities of sulfated polysaccharides from tropical 
seaweeds. Biomedicine & Pharmacotherapy. 2010;64(1):21-28
[51] Mayer AM, Rodraguez AD, et al. Marine pharmacology in 2007: Marine compounds 
with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antipro-
tozoal, antituberculosis, and antiviral activities; affecting the immune and nervous sys-
tem, and other miscellaneous mechanisms of action. Comparative Biochemistry and 
Physiology Part C: Toxicology & Pharmacology. 2011;153(2):191-222
[52] Opoku G, Qiu X, et al. Effect of oversulfation on the chemical and biological properties 
of kappa carrageenan. Carbohydrate Polymers. 2006;65(2):134-138
[53] Chiu YH, Chan YL, et al. Prevention of human enterovirus 71 infection by kappa car-
rageenan. Antiviral Research. 2012;95(2):128-134
[54] Wang W, Zhang P, et al. Preparation and anti-influenza A virus activity of Î°-carrageenan 
oligosaccharide and its sulphated derivatives. Food Chemistry. 2012;133(3):880-888
Seaweed Biomaterials22
[55] Li YX, Wijesekara I, et al. Phlorotannins as bioactive agents from brown algae. Process 
Biochemistry. 2011;46(12):2219-2224
[56] Miyashita K, Hosokawa M. 12 beneficial health effects of seaweed carotenoid, fucoxan-
thin. In: Marine Nutraceuticals and Functional Foods. New York: CRC; 2007. p. 297
[57] Hosakawa M, Bhaskar N, et al. Fucoxanthin as a bioactive and nutritionally beneficial 
marine carotenoid: A review. Carotenoid Science. 2006;10:15-28
[58] Ngo DH, Wijesekara I, et al. Marine food-derived functional ingredients as poten-
tial antioxidants in the food industry: An overview. Food Research International. 
2011;44(2):523-529
[59] Cornish ML, Garbary DJ. Antioxidants from macroalgae: Potential applications in 
human health and nutrition. Algae. 2010;25(4):155-171
[60] Mendis E, Rajapakse N, et al. Investigation of jumbo squid (Dosidicus gigas) skin gelatin 
peptides for their in vitro antioxidant effects. Life Sciences. 2005;77(17):2166-2178
[61] Mendis E, Rajapakse N, et al. Antioxidant properties of a radical-scavenging pep-
tide purified from enzymatically prepared fish skin gelatin hydrolysate. Journal of 
Agricultural and Food Chemistry. 2005;53(3):581-587
[62] Cho M, Lee HS, et al. Antioxidant properties of extract and fractions from Enteromorpha 
prolifera, a type of green seaweed. Food Chemistry. 2011;127(3):999-1006
[63] Raza A, Butt MS, Suleria HAR. Jamun (Syzygium cumini) seed and fruit extract atten-
uate hyperglycemia in diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 
2017;7(8):750-754
[64] Jun SY, Park PJ, et al. Purification and characterization of an antioxidative peptide from 
enzymatic hydrolysate of yellowfin sole (Limanda aspera) frame protein. European Food 
Research and Technology. 2004;219(1):20-26
[65] Sachindra NM, Sato E, et al. Radical scavenging and singlet oxygen quenching activity 
of marine carotenoid fucoxanthin and its metabolites. Journal of Agricultural and Food 
Chemistry. 2007;55(21):8516-8522
[66] Heo SJ, Ko SC, et al. Cytoprotective effect of fucoxanthin isolated from brown algae 
Sargassum siliquastrum against H
2
O
2
-induced cell damage. European Food Research and 
Technology. 2008;228(1):145-151
[67] Jung WK, Je JY, et al. A novel anticoagulant protein from Scapharca broughtonii. BMB 
Reports. 2002;35(2):199-205
[68] Jo HY, Jung WK, et al. Purification and characterization of a novel anticoagulant peptide 
from marine echiuroid worm, Urechis unicinctus. Process Biochemistry. 2008;43(2):179-184
[69] Kim SK, Pangestuti R. Potential role of marine algae on female health, beauty, and lon-
gevity. Advances in Food and Nutrition Research. 2011;64:41-55
[70] Mestechkina N, Shcherbukhin V. Sulfated polysaccharides and their anticoagulant activ-
ity: A review. Applied Biochemistry and Microbiology. 2010;46(3):267-273
Therapeutic Potential of Seaweed Bioactive Compounds
http://dx.doi.org/10.5772/intechopen.74060
23
[71] Maeda M, Uehara T, et al. Heparinoid-active sulphated polysaccharides from Monostroma 
nitidum and their distribution in the chlorophyta. Phytochemistry. 1991;30(11):3611-3614
[72] Silva F, Dore C, et al. Anticoagulant activity, paw edema and pleurisy induced carra-
geenan: Action of major types of commercial carrageenans. Carbohydrate Polymers. 
2010;79(1):26-33
[73] Shanmugam M, Mody K. Heparinoid-active sulphated polysaccharides from marine 
algae as potential blood anticoagulant agents. Current Science. 2000;79(12):1672-1683
[74] Yuan YV, Walsh NA. Antioxidant and antiproliferative activities of extracts from a vari-
ety of edible seaweeds. Food and Chemical Toxicology. 2006;44(7):1144-1150
[75] Sithranga Boopathy N, Kathiresan K. Anticancer drugs from marine flora: An overview. 
Journal of Oncology. 2010;1-18. http://dx.doi.org/10.1155/2010/214186
[76] Cho EJ, Rhee SH, et al. Antimutagenic and cancer cell growth inhibitory effects of sea-
weeds. Preventive Nutrition and Food Science. 1997;2(4):348-353
[77] Yubin J, Guangmei Z. Pharmacological Action and Application of Available Antitumor 
Composition of Traditional Chinese Medicine. Heilongjiang, China: Heilongjiang 
Science and Technology Press; 1998
[78] Haroun F, Lindenmeyer F, et al. In vitro effect of fucans on MDA-MB231 tumor cell 
adhesion and invasion. Anticancer Research. 2002;22:214-221
[79] Yamamoto I, Maruyama H, et al. The effect of dietary or intraperitoneally injected sea-
weed preparations on the growth of sarcoma-180 cells subcutaneously implanted into 
mice. Cancer Letters. 1986;30(2):125-131
[80] Okai Y, Higashi-Okai K, et al. Identification of antimutagenic substances in an extract 
of edible red alga, Porphyra tenera (Asadusa-nori). Cancer Letters. 1996;100(1-2):235-240
[81] Givens DI, Gibbs RA. Current intakes of EPA and DHA in European populations and 
the potential of animal-derived foods to increase them: Symposium on how can the n-3 
content of the diet be improved? Proceedings of the Nutrition Society. 2008;67(3):273-280
[82] Jiao G, Yu G, et al. Chemical structures and bioactivities of sulfated polysaccharides 
from marine algae. Marine Drugs. 2011;9(2):196-223
[83] Launay S, Hermine O, et al. Vital functions for lethal caspases. Oncogene. 2005;24(33):5137
[84] Fan TJ, Han LH, et al. Caspase family proteases and apoptosis. Acta Biochimica et 
Biophysica Sinica. 2005;37(11):719-727
[85] Hart AN, Zaske LA, et al. Natural killer cell activation and modulation of chemokine 
receptor profile in vitro by an extract from the cyanophyta Aphanizomenon flos-aquae. 
Journal of Medicinal Food. 2007;10(3):435-441
[86] Hiqashi-Okaj K, Otani S, et al. Potent suppressive effect of a Japanese edible seaweed, 
Enteromorpha prolifera (Sujiao-nori) on initiation and promotion phases of chemically 
induced mouse skin tumorigenesis. Cancer Letters. 1999;140(1):21-25
Seaweed Biomaterials24
[87] Burja AM, Banaigs B, et al. Marine cyanobacteriaaea prolific source of natural products. 
Tetrahedron. 2001;57(46):9347-9377
[88] Vo TS, Kim SK. Potential anti-HIV agents from marine resources: An overview. Marine 
Drugs. 2010;8(12):2871-2892
[89] Adhikari U, Mateu CG. Structure and antiviral activity of sulfated fucans from 
Stoechospermum marginatum. Phytochemistry. 2006;67(22):2474-2482
[90] Queiroz K, Medeiros V, et al. Inhibition of reverse transcriptase activity of HIV by poly-
saccharides of brown algae. Biomedicine & Pharmacotherapy. 2008;62(5):303-307
[91] Lehtinen M, Dillner J. Preventive Human Papillomavirus Vaccination. The Medical 
Society for the Study of Venereal Disease; London; 2002
[92] Campo VL, Kawano DFB, et al. Carrageenans: Biological properties, chemical modifi-
cations and structural analysis: A review. Carbohydrate Polymers. 2009;77(2):167-180
[93] Buck CB, Thompson CD, et al. Carrageenan is a potent inhibitor of papillomavirus 
infection. PLoS Pathogens. 2006;2(7):e69
[94] Scicchitano P, Cameli M, et al. Nutraceuticals and dyslipidaemia: Beyond the common 
therapeutics. Journal of Functional Foods. 2014, 2014;6:11-32
[95] Komprda TA. Eicosapentaenoic and docosahexaenoic acids as inflammation-modulat-
ing and lipid homeostasis influencing nutraceuticals: A review. Journal of Functional 
Foods. 2012;4(1):25-38
[96] Zedler S, Faist E. The impact of endogenous triggers on trauma-associated inflamma-
tion. Current Opinion in Critical Care. 2006;12(6):595-601
[97] Nguyen MHT, Jung WK, et al. Marine algae possess therapeutic potential for 
Ca-mineralization via osteoblastic differentiation. Advances in Food and Nutrition 
Research. 2011;64:429-441
[98] Cui Y, Luo D, et al. Fucoidan: Advances in the study of its anti-inflammatory and anti-
oxidative effects. Yao Xue Xue Bao [Acta Pharmaceutica Sinica]. 2008;43(12):1186-1189
[99] Medeiros V, Queiroz K, et al. Sulfated galactofucan from Lobophora variegata: 
Anticoagulant and anti-inflammatory properties. Biochemistry (Moscow). 2008;73(9): 
1018-1024
[100] Ngatu NR, Okajima MK, et al. Anti-inflammatory effects of sacran, a novel polysaccha-
ride from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene-induced allergic dermati-
tis in vivo. Annals of Allergy, Asthma & Immunology. 2012;108(2):117-122. e2
[101] Huang R, Zhou X, et al. Diketopiperazines from marine organisms. Chemistry & 
Biodiversity. 2010;7(12):2809-2829
[102] Heo SJ, Yoon WJ, et al. Evaluation of anti-inflammatory effect of fucoxanthin isolated 
from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food 
and Chemical Toxicology. 2010;48(8):2045-2051
[103] Gaven KMC, Percot A, et al. Alkaloids in marine algae. Marine Drugs. 2010;8(2):269-284
Therapeutic Potential of Seaweed Bioactive Compounds
http://dx.doi.org/10.5772/intechopen.74060
25

